de Brown Advisory iShares US Pharmaceuticals ETF IHE Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 7.47 M | Mantener |
75,432
| – | – | 0.01% | 480 |
|
|
2026
Q1 | USD 6.54 M | Mantener |
75,432
| – | – | 0.01% | 479 |
|
|
2025
Q4 | USD 6.4 M | Mantener |
75,432
| – | – | 0.01% | 497 |
|
|
2025
Q3 | USD 5.47 M | Mantener |
75,432
| – | – | 0.01% | 516 |
|
|
2025
Q2 | USD 4.94 M | Vender |
75,432
-15,635
| -17% | -USD 1.02 M | 0.01% | 514 |
|
|
2025
Q1 | USD 6.43 M | Vender |
91,067
-900
| -1% | -USD 62.5 k | 0.01% | 470 |
|
|
2024
Q4 | USD 6.04 M | Vender |
91,967
-2,410
| -3% | -USD 166 k | 0.01% | 500 |
|
|
2024
Q3 | USD 6.66 M | Mantener |
94,377
| – | – | 0.01% | 466 |
|
|
2024
Q2 | USD 6.26 M | Vender |
94,377
-2,625
| -3% | -USD 172 k | 0.01% | 466 |
|
|
2024
Q1 | USD 6.59 M | Mantener |
97,002
| – | – | 0.01% | 460 |
|
|
2023
Q4 | USD 5.99 M | Mantener |
97,002
| – | – | 0.01% | 461 |
|
|
2023
Q3 | USD 5.72 M | Mantener |
97,002
| – | – | 0.01% | 456 |
|
|
2023
Q2 | USD 5.79 M | Vender |
97,002
-14,103
| -13% | -USD 838 k | 0.01% | 461 |
|
|
2023
Q1 | USD 6.49 M | Mantener |
111,105
| – | – | 0.01% | 441 |
|
|
2022
Q4 | USD 6.89 M | Vender |
111,105
-120
| -0.1% | -USD 7.22 k | 0.01% | 427 |
|
|
2022
Q3 | USD 6.29 M | Vender |
111,225
-93
| -0.1% | -USD 5.73 k | 0.01% | 422 |
|
|
2022
Q2 | USD 7.11 M | Mantener |
111,318
| – | – | 0.01% | 411 |
|
|
2022
Q1 | USD 7.21 M | Vender |
111,318
-720
| -0.6% | -USD 45.6 k | 0.01% | 426 |
|
|
2021
Q4 | USD 7.46 M | Vender |
112,038
-480
| -0.4% | -USD 30.4 k | 0.01% | 427 |
|
|
2021
Q3 | USD 6.87 M | Vender |
112,518
-300
| -0.3% | -USD 19.1 k | 0.01% | 417 |
|
|
2021
Q2 | USD 6.98 M | Vender |
112,818
-7,512
| -6% | -USD 457 k | 0.01% | 418 |
|
|
2021
Q1 | USD 7.13 M | Mantener |
120,330
| – | – | 0.01% | 410 |
|
|
2020
Q4 | USD 7.2 M | Vender |
120,330
-1,800
| -1% | -USD 103 k | 0.01% | 384 |
|
|
2020
Q3 | USD 6.66 M | Vender |
122,130
-549
| -0.4% | -USD 29.6 k | 0.01% | 371 |
|
|
2020
Q2 | USD 6.29 M | Vender |
122,679
-393
| -0.3% | -USD 19.8 k | 0.01% | 366 |
|
|
2020
Q1 | USD 5.52 M | Vender |
123,072
-8,715
| -7% | -USD 440 k | 0.02% | 359 |
|
|
2019
Q4 | USD 7.03 M | Vender |
131,787
-15,000
| -10% | -USD 739 k | 0.02% | 372 |
|
|
2019
Q3 | USD 6.84 M | Vender |
146,787
-19,290
| -12% | -USD 924 k | 0.02% | 368 |
|
|
2019
Q2 | USD 8.35 M | Vender |
166,077
-699
| -0.4% | -USD 34.6 k | 0.02% | 342 |
|
|
2019
Q1 | USD 8.56 M | Vender |
166,776
-15,135
| -8% | -USD 753 k | 0.02% | 369 |
|
|
2018
Q4 | USD 8.54 M | Vender |
181,911
-10,230
| -5% | -USD 524 k | 0.03% | 348 |
|
|
2018
Q3 | USD 10.8 M | Comprar |
192,141
+8,550
| +5% | +USD 467 k | 0.03% | 325 |
|
|
2018
Q2 | USD 9.26 M | Vender |
183,591
-60
| -0% | -USD 2.97 k | 0.03% | 341 |
|
|
2018
Q1 | USD 9.03 M | Vender |
183,651
-3,540
| -2% | -USD 182 k | 0.03% | 318 |
|
|
2017
Q4 | USD 9.6 M | Vender |
187,191
-2,238
| -1% | -USD 115 k | 0.03% | 321 |
|
|
2017
Q3 | USD 9.9 M | Vender |
189,429
-1,560
| -0.8% | -USD 80.1 k | 0.03% | 307 |
|
|
2017
Q2 | USD 9.9 M | Vender |
190,989
-3,510
| -2% | -USD 177 k | 0.03% | 316 |
|
|
2017
Q1 | USD 9.8 M | Vender |
194,499
-15,615
| -7% | -USD 773 k | 0.03% | 295 |
|
|
2016
Q4 | USD 9.9 M | Vender |
210,114
-22,995
| -10% | -USD 1.09 M | 0.04% | 290 |
|
|
2016
Q3 | USD 11.6 M | Vender |
233,109
-4,365
| -2% | -USD 221 k | 0.04% | 269 |
|
|
2016
Q2 | USD 11.4 M | Vender |
237,474
-15,195
| -6% | -USD 723 k | 0.04% | 265 |
|
|
2016
Q1 | USD 11.5 M | Vender |
252,669
-13,998
| -5% | -USD 655 k | 0.04% | 251 |
|
|
2015
Q4 | USD 14.4 M | Comprar |
266,667
+7,773
| +3% | +USD 409 k | 0.05% | 223 |
|
|
2015
Q3 | USD 12.8 M | Comprar |
258,894
+9,690
| +4% | +USD 555 k | 0.05% | 233 |
|
|
2015
Q2 | USD 14.5 M | Vender |
249,204
-10,170
| -4% | -USD 594 k | 0.05% | 234 |
|
|
2015
Q1 | USD 14.9 M | Comprar |
259,374
+3,150
| +1% | +USD 172 k | 0.05% | 228 |
|
|
2014
Q4 | USD 12.9 M | Vender |
256,224
-10,770
| -4% | -USD 525 k | 0.04% | 243 |
|
|
2014
Q3 | USD 12.5 M | Comprar |
266,994
+7,650
| +3% | +USD 345 k | 0.04% | 241 |
|
|
2014
Q2 | USD 11.7 M | Comprar |
259,344
+21,015
| +9% | +USD 904 k | 0.04% | 240 |
|
|
2014
Q1 | USD 10.1 M | Vender |
238,329
-3,180
| -1% | -USD 133 k | 0.03% | 256 |
|
|
2013
Q4 | USD 9.5 M | Comprar |
241,509
+13,635
| +6% | +USD 512 k | 0.03% | 255 |
|
|
2013
Q3 | USD 8.08 M | Comprar |
227,874
+11,730
| +5% | +USD 413 k | 0.03% | 261 |
|
|
2013
Q2 | USD 7.18 M | Comprar |
+216,144
| Nuevas | +USD 7.18 M | 0.03% | 259 |
|
Otros fondos que tienen IHE en su cartera
Posición de Brown Advisory en IHE: resumen de T2 2026
Brown Advisory mantuvo sin cambios su posición en iShares US Pharmaceuticals ETF (IHE) en T2 2026, con 75,432 acciones por un valor de USD 7.47 M. La posición representa 0.01% de la cartera y ocupa el puesto #480.
Brown Advisory reportó por primera vez una posición en IHE en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 14.9 M en T1 2015. Al cierre de T2 2026, 210 fondos que sigue Wall St. Rank mantienen una posición en IHE.
- Al cierre de T2 2026, Brown Advisory tenía 75,432 acciones de iShares US Pharmaceuticals ETF con un valor de USD 7.47 M.
- Brown Advisory mantuvo sin cambios su número de acciones de iShares US Pharmaceuticals ETF en T2 2026.
- iShares US Pharmaceuticals ETF representó 0.01% de la cartera de Brown Advisory en T2 2026 y fue su posición número 480.
- Brown Advisory reportó por primera vez una posición en iShares US Pharmaceuticals ETF en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Brown Advisory en iShares US Pharmaceuticals ETF alcanzó su máximo de USD 14.9 M en T1 2015.
- Al cierre de T2 2026, 210 fondos que sigue Wall St. Rank tenían iShares US Pharmaceuticals ETF en cartera.
Según el Informe 13F de Brown Advisory correspondiente a T2 2026, presentado el 14 ago 2026.